HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bin Liang Selected Research

10-hydroxycamptothecin

1/2013Hepatic parenchymal changes following transcatheter embolization and chemoembolization in a rabbit tumor model.
11/2011Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model.
10/2010Experimental evaluation of inhibitory effect of 10-hydroxycamptothecin on hypoxia-inducible factor-1α expression and angiogenesis in liver tumors after transcatheter arterial embolization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bin Liang Research Topics

Disease

83Neoplasms (Cancer)
10/2022 - 03/2002
21Hepatocellular Carcinoma (Hepatoma)
06/2022 - 04/2004
15Inflammation (Inflammations)
01/2022 - 09/2010
13Atherosclerosis
01/2022 - 02/2010
10Liver Neoplasms (Liver Cancer)
07/2022 - 01/2013
9Neoplasm Metastasis (Metastasis)
06/2022 - 02/2014
9Carcinoma (Carcinomatosis)
01/2022 - 01/2003
9Stomach Neoplasms (Stomach Cancer)
04/2021 - 01/2003
8Necrosis
07/2022 - 11/2011
8Hypoxia (Hypoxemia)
07/2022 - 12/2009
8Hypertension (High Blood Pressure)
11/2021 - 05/2011
7Infections
07/2022 - 11/2004
7Lymphatic Metastasis
06/2022 - 01/2013
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2015
7Obesity
01/2021 - 08/2015
7Carcinogenesis
07/2020 - 01/2003
6Hemorrhage
01/2021 - 03/2011
5Type 2 Diabetes Mellitus (MODY)
05/2022 - 04/2013
5Lung Neoplasms (Lung Cancer)
01/2022 - 04/2012
5Non-alcoholic Fatty Liver Disease
01/2022 - 11/2015
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2020
5Breast Neoplasms (Breast Cancer)
08/2021 - 03/2002
4Rectal Neoplasms (Rectal Cancer)
10/2022 - 11/2014
4Fever (Fevers)
06/2022 - 01/2020
4Thrombosis (Thrombus)
05/2022 - 09/2010
4Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2011
4Prostatic Neoplasms (Prostate Cancer)
08/2021 - 01/2019
4Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2020 - 04/2007
4Colorectal Neoplasms (Colorectal Cancer)
05/2019 - 04/2008
4Metabolic Diseases (Metabolic Disease)
01/2019 - 03/2013
4Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018 - 11/2004
4Cysts
11/2015 - 11/2014
3Vomiting
06/2022 - 01/2021
3Pathologic Constriction (Stenosis)
01/2022 - 09/2010
3Fibrosis (Cirrhosis)
01/2022 - 06/2016
3Pain (Aches)
01/2022 - 01/2020
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2018
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 01/2018
3Atherosclerotic Plaque (Atheroma)
01/2022 - 01/2014
3Adenocarcinoma
04/2021 - 01/2017
3Ascites
01/2021 - 06/2012
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 01/2018
3Cytokine Release Syndrome
01/2021 - 10/2009
3Wounds and Injuries (Trauma)
11/2019 - 01/2019
3Pleural Effusion (Pleural Effusions)
01/2018 - 01/2012
3Shock
07/2017 - 03/2011
3Body Weight (Weight, Body)
10/2016 - 10/2010
3Choledochal Cyst (Choledochal Cysts)
11/2015 - 07/2013
3Ovarian Neoplasms (Ovarian Cancer)
01/2015 - 01/2013
3Alzheimer Disease (Alzheimer's Disease)
01/2014 - 09/2010

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
12/2022 - 03/2002
14Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2011
13LipidsIBA
01/2021 - 08/2012
12Pharmaceutical PreparationsIBA
07/2022 - 12/2002
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 08/2010
8Messenger RNA (mRNA)IBA
01/2020 - 04/2004
7MicroRNAs (MicroRNA)IBA
12/2022 - 01/2017
6RNA (Ribonucleic Acid)IBA
01/2021 - 01/2016
5apatinibIBA
06/2022 - 01/2020
5Therapeutic UsesIBA
12/2020 - 01/2014
5oxidized low density lipoproteinIBA
10/2018 - 06/2010
5CholesterolIBA
09/2017 - 12/2014
4BilirubinIBA
01/2021 - 01/2020
4Member 1 Group A Nuclear Receptor Subfamily 4IBA
01/2019 - 12/2015
4Tumor Biomarkers (Tumor Markers)IBA
12/2018 - 01/2012
4AMP-Activated Protein KinasesIBA
03/2013 - 02/2010
3Triglycerides (Triacylglycerol)IBA
12/2022 - 11/2015
3Fatty Acids (Saturated Fatty Acids)IBA
12/2022 - 07/2020
3thiamine triphosphorate (TTP)IBA
06/2022 - 01/2020
3Biological ProductsIBA
01/2022 - 01/2017
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2010
3Indicators and Reagents (Reagents)IBA
01/2022 - 01/2013
3CytokinesIBA
01/2022 - 10/2009
3Sorafenib (BAY 43-9006)FDA Link
10/2021 - 01/2021
3Blood Glucose (Blood Sugar)IBA
01/2021 - 08/2012
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021 - 11/2011
3Alanine Transaminase (SGPT)IBA
01/2021 - 11/2011
3Circular RNAIBA
10/2020 - 01/2020
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 01/2013
3EnzymesIBA
01/2020 - 06/2012
3Peptides (Polypeptides)IBA
11/2019 - 10/2009
3Starch (Cornstarch)IBA
11/2019 - 03/2011
3Long Noncoding RNAIBA
01/2019 - 01/2019
3AngiotensinsIBA
02/2018 - 12/2014
3Protein Kinases (Protein Kinase)IBA
06/2014 - 02/2005
3Adenosine Monophosphate (AMP)IBA
06/2014 - 05/2011
3Vascular Endothelial Growth Factor CIBA
02/2014 - 01/2013
310-hydroxycamptothecinIBA
01/2013 - 10/2010
3EndostatinsIBA
11/2012 - 04/2012
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
12/2022 - 11/2015

Therapy/Procedure

23Therapeutics
07/2022 - 01/2011
13Drug Therapy (Chemotherapy)
01/2020 - 03/2002
5Microspheres (Microsphere)
07/2022 - 04/2015
4Gastrectomy
04/2021 - 03/2015
4Aftercare (After-Treatment)
01/2020 - 01/2013
3Immunotherapy
01/2022 - 07/2008
3Radiofrequency Ablation
04/2021 - 01/2018
3Radiotherapy
01/2019 - 01/2019
3Hematopoietic Stem Cell Transplantation
01/2018 - 01/2010
3Proctectomy
04/2016 - 11/2014